Your browser doesn't support javascript.
loading
TRRAP is a central regulator of human multiciliated cell formation.
Wang, Zhao; Plasschaert, Lindsey W; Aryal, Shivani; Renaud, Nicole A; Yang, Zinger; Choo-Wing, Rayman; Pessotti, Angelica D; Kirkpatrick, Nathaniel D; Cochran, Nadire R; Carbone, Walter; Maher, Rob; Lindeman, Alicia; Russ, Carsten; Reece-Hoyes, John; McAllister, Gregory; Hoffman, Gregory R; Roma, Guglielmo; Jaffe, Aron B.
Affiliation
  • Wang Z; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Plasschaert LW; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Aryal S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Renaud NA; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Yang Z; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Choo-Wing R; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Pessotti AD; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Kirkpatrick ND; Analytical Sciences and Imaging, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Cochran NR; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Carbone W; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Maher R; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Lindeman A; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Russ C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Reece-Hoyes J; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • McAllister G; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Hoffman GR; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
  • Roma G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Jaffe AB; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA aron.jaffe@novartis.com.
J Cell Biol ; 217(6): 1941-1955, 2018 06 04.
Article in En | MEDLINE | ID: mdl-29588376
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Cilia / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Cell Biol Year: 2018 Document type: Article Affiliation country: Morocco Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Cilia / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Cell Biol Year: 2018 Document type: Article Affiliation country: Morocco Country of publication: United States